INS and diabetic cardiomyopathy: Since the beneficial actions of sarpogrelate treatment in diabetic cardiomyopathy were similar to those of insulin treatment [32], the effects of insulin treatment on subcellular remodeling in diabetic animals were also studied for the purpose of comparison with sarpogrelate.